You're reading the free version. Trader adds the live tape and alerts.
Start tracking
OTLK Award Disclosure
Kenyon Lawrence A · SEC Form 4 · Filed Jul 23, 2026
Award
Calculated transaction value
$0
Kenyon Lawrence A Chief Financial Officer
OTLK
Outlook Therapeutics
OTLK
Transaction date
Jul 21, 2026
Public filing date
Jul 23, 2026
Filing lag
Filed 2 days later
OTLK daily price context
Close on/before transaction
$1.42
Jul 21, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 210,078 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001649989-26-000007
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Outlook Therapeutics, Inc. OTLK Current | Award | Jul 21, 2026 | $0 |